William R. Hiatt, MD, is the Novartis Foundation endowed professor for cardiovascular research at the University of Colorado School of Medicine, Division of Cardiology with a clinical focus in vascular medicine. He is president of CPC which is a university-affiliated, non-profit cardiovascular and clinical trials research organization. Active in many national societies, Dr Hiatt is a past-president of the Society for Vascular Medicine and is a fellow in the American Heart Association and the American College of Physicians. He is currently the chair of the American Heart Association Peripheral Vascular Disease Council. Dr Hiatt also serves on the editorial board as an associate editor for the Journal of Vascular Medicine, the Cochrane Review Group and is guest editor for Circulation and the Journal of the American College of Cardiology. Dr Hiatt is the immediate past chairman of the United States Food and Drug Administration Cardiovascular and Renal Advisory Committee (2003-08). He has received two outstanding medical student teacher awards and has been elected several times as Best Doctors in America. In 2008 he received the Robert W. Schrier Award of Excellence from the Department of Medicine, University of Colorado and he received the Julius H. Jacobson II, MD Physician Excellence Award from the Vascular Disease Foundation. Research activities include studies evaluating the pathophysiology and epidemiology of peripheral artery disease, mechanisms of supervised exercise as an effective treatment modality for claudication, and numerous clinical trials to develop new therapies for claudication and critical leg ischemia. His research at the CPC has pioneered new methods to control endpoint variability in clinical trials. Dr. Hiatt has over 180 peer-reviewed publications.
Dr Hiatt was born in Denver, Colorado in 1950, received his medical degree cum laude from the University of Colorado School of Medicine in 1976, and was elected to the Alpha Omega Alpha medical society. He completed his residency training at Boston University Hospital, Boston, Massachusetts, and the University of Colorado Health Sciences Center in 1979. He was a fellow in internal medicine and vascular medicine at the University of Colorado from 1979 to 1981, and then joined the University of Colorado faculty in 1981.
The CPC is a global, full service clinical trials organization in cardiovascular medicine that directs study design and provides academic oversight of trials of drugs, biologic agents and device therapies for peripheral artery disease. The organization also has funding from the State of Colorado to screen and navigate citizens at high risk for cardiovascular disease into appropriate preventive health care.